Last reviewed · How we verify

NCT02899780

Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light

Withdrawn NA Last updated 30 October 2018
What this trial tests

NA trial testing Ultraviolet light emitting optical fiber in Catheter-Related Infections. Withdrawn.

Timeline
11 May 2017
Primary endpoint
10 May 2018
10 May 2018

Quick facts

Lead sponsorUltraviolet Interventions
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date11 May 2017
Primary completion10 May 2018
Estimated completion10 May 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ultraviolet Interventions

Who can join

18 and older, any sex, with Catheter-Related Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a first-in-man clinical trial using fiber optically delivered ultraviolet light for reducing viable bacteria within indwelling tunneled dialysis catheters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Catheter-Related Infections

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02899780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing